Study of CX-4945 in Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT01199718 · UNKNOWN
Trial details
- NCT number
- NCT01199718
- Sponsor
- Cylene Pharmaceuticals
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2011-06-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.